Should You Buy Viatris Inc (VTRS) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Viatris Inc (VTRS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is undervalued with a strong analyst sentiment, positive news catalysts, and a bullish technical setup. Despite weak financial performance in the last quarter, the company's strategic initiatives and recent drug launch position it well for long-term growth.
Technical Analysis
The stock shows a bullish trend with SMA_5 > SMA_20 > SMA_200, indicating upward momentum. The RSI is neutral at 65.844, and the MACD is below zero but negatively contracting, suggesting a potential reversal. Key support is at 12.634, and resistance is at 13.367, with the current pre-market price at 13.215, close to the pivot level of 13.001.
